The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2017-12

AUTHORS

Ravi S. Narayan, Carlos A. Fedrigo, Eelke Brands, Rogier Dik, Lukas J.A. Stalpers, Brigitta G. Baumert, Ben J. Slotman, Bart A. Westerman, Godefridus J. Peters, Peter Sminia

ABSTRACT

BACKGROUND: Glioblastoma multiforme (GBM) is the most common, invasive and deadly primary type of malignant brain tumor. The Phosphatidylinositol-3-Kinase/AKT (PI3K/AKT) pathway is highly active in GBM and has been associated with increased survival and resistance to therapy. The aim of this study is to investigate the effects of AKT inhibition in combination with the current standard of care which consists of irradiation and temozolomide (TMZ) on human malignant glioma cells growing adherent and as multicellular spheroids in vitro. METHODS: The effects of the allosteric inhibitor MK2206 combined with irradiation and TMZ were assessed on glioma cells growing adherent and as multicellular 3D spheroids. The interaction was studied on proliferation, clonogenic cell survival, cell invasion, -migration and on expression of key proteins in the PI3K-AKT pathway by western blot. RESULTS: A differential effect was found at low- (1 μM) and high dose (10 μM) MK2206. At 1 μM, the inhibitor reduced phosphorylation of Thr308 and Ser473 residues of AKT in both adherent cells and spheroids. Low dose MK2206 delayed spheroid growth and sensitized spheroids to both irradiation and TMZ in a synergistic way (Combination index <0.35). In contrast, neither low nor high dose MK2206 did enhance therapy sensitivity in adherent growing cells. Effective inhibition of invasion and migration was observed only at higher doses of MK2206 (>5 μM). CONCLUSIONS: The data show that a 3D spheroid model show different sensitivity to irradiation when combined with AKT inhibition. Thereby we show that MK2206 has potential synergistic efficacy to the current standard of care for glioma patients. More... »

PAGES

204

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12885-017-3193-9

DOI

http://dx.doi.org/10.1186/s12885-017-3193-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1084250541

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28320338


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Alkylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blotting, Western", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dacarbazine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Synergism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glioblastoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heterocyclic Compounds, 3-Ring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphatidylinositol 3-Kinase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phosphorylation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins c-akt", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spheroids, Cellular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Temozolomide", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Narayan", 
        "givenName": "Ravi S.", 
        "id": "sg:person.01107655364.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107655364.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fedrigo", 
        "givenName": "Carlos A.", 
        "id": "sg:person.01350727612.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350727612.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brands", 
        "givenName": "Eelke", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dik", 
        "givenName": "Rogier", 
        "id": "sg:person.014562057203.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014562057203.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Academic Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.5650.6", 
          "name": [
            "Department of Radiation Oncology, Academic Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stalpers", 
        "givenName": "Lukas J.A.", 
        "id": "sg:person.011141072757.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011141072757.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Maastro Clinic", 
          "id": "https://www.grid.ac/institutes/grid.426577.5", 
          "name": [
            "Clinical Cooperation Unit Neurooncology, MediClin Robert Janker Klinik & University of Bonn Medical Center, Bonn, Germany", 
            "Department of Radiation Oncology, Maastro Clinic, Maastricht, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Baumert", 
        "givenName": "Brigitta G.", 
        "id": "sg:person.0641065010.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641065010.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Slotman", 
        "givenName": "Ben J.", 
        "id": "sg:person.01112041340.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112041340.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Neurosurgery, Neuro Oncology Research Group, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Westerman", 
        "givenName": "Bart A.", 
        "id": "sg:person.0721552575.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721552575.80"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "VU University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.16872.3a", 
          "name": [
            "Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peters", 
        "givenName": "Godefridus J.", 
        "id": "sg:person.01255301342.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255301342.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sminia", 
        "givenName": "Peter", 
        "id": "sg:person.0676345051.76", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676345051.76"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70025-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002463620"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1741-7007-10-29", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006008752", 
          "https://doi.org/10.1186/1741-7007-10-29"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nop026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007120656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-14-0708", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007436827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-016-2220-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008754431", 
          "https://doi.org/10.1007/s11060-016-2220-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11060-016-2220-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008754431", 
          "https://doi.org/10.1007/s11060-016-2220-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.mrfmmm.2011.03.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013050931"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1541-7786.mcr-11-0592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013402033"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1242/jcs.00712", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016424950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-09-1012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016692533"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/neuonc/nou223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019576806"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-11-0606", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019719324"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00401-016-1545-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021788062", 
          "https://doi.org/10.1007/s00401-016-1545-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/pcmr.12227", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022196975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.35.5263", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022896731"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrclinonc.2013.10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031948211", 
          "https://doi.org/10.1038/nrclinonc.2013.10"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-8722-7-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033613173", 
          "https://doi.org/10.1186/1756-8722-7-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00210-014-1032-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033781917", 
          "https://doi.org/10.1007/s00210-014-1032-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/82_2010_67", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034849918", 
          "https://doi.org/10.1007/82_2010_67"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/82_2010_67", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034849918", 
          "https://doi.org/10.1007/82_2010_67"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1369/0022155411400867", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035146448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1369/0022155411400867", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035146448"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2011.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042768064"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.gene.2004.04.032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043587272"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cell.2013.09.034", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044472205"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-12-1141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045845537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-10-2889", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047303951"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-015-0475-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049118084", 
          "https://doi.org/10.1186/s13014-015-0475-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.06053-11", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049824220"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-15-2402", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051494246"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1432-1033.1981.tb06218.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052409919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/138161213804547286", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1069168528"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/br.2016.594", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071502597"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/15384047.2014.961876", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072288009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cbt.25939", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072292971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4161/cc.10.13.16305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072295972"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079157684", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083005077", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "BACKGROUND: Glioblastoma multiforme (GBM) is the most common, invasive and deadly primary type of malignant brain tumor. The Phosphatidylinositol-3-Kinase/AKT (PI3K/AKT) pathway is highly active in GBM and has been associated with increased survival and resistance to therapy. The aim of this study is to investigate the effects of AKT inhibition in combination with the current standard of care which consists of irradiation and temozolomide (TMZ) on human malignant glioma cells growing adherent and as multicellular spheroids in vitro.\nMETHODS: The effects of the allosteric inhibitor MK2206 combined with irradiation and TMZ were assessed on glioma cells growing adherent and as multicellular 3D spheroids. The interaction was studied on proliferation, clonogenic cell survival, cell invasion, -migration and on expression of key proteins in the PI3K-AKT pathway by western blot.\nRESULTS: A differential effect was found at low- (1\u00a0\u03bcM) and high dose (10\u00a0\u03bcM) MK2206. At 1\u00a0\u03bcM, the inhibitor reduced phosphorylation of Thr308 and Ser473 residues of AKT in both adherent cells and spheroids. Low dose MK2206 delayed spheroid growth and sensitized spheroids to both irradiation and TMZ in a synergistic way (Combination index <0.35). In contrast, neither low nor high dose MK2206 did enhance therapy sensitivity in adherent growing cells. Effective inhibition of invasion and migration was observed only at higher doses of MK2206 (>5\u00a0\u03bcM).\nCONCLUSIONS: The data show that a 3D spheroid model show different sensitivity to irradiation when combined with AKT inhibition. Thereby we show that MK2206 has potential synergistic efficacy to the current standard of care for glioma patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12885-017-3193-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024632", 
        "issn": [
          "1471-2407"
        ], 
        "name": "BMC Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures", 
    "pagination": "204", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "becaedf7c320b6d1374970cf95f398c081e03d059484160acc593c2382fb9096"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28320338"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100967800"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12885-017-3193-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1084250541"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12885-017-3193-9", 
      "https://app.dimensions.ai/details/publication/pub.1084250541"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113670_00000004.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12885-017-3193-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3193-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3193-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3193-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-017-3193-9'


 

This table displays all metadata directly associated to this object as RDF triples.

325 TRIPLES      21 PREDICATES      80 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12885-017-3193-9 schema:about N078840cc60fa44d18cdde46558b752b5
2 N0a52156e22ff478bb652c95474b53911
3 N10c090810eb34f078e902de000a50602
4 N123bb7312e3f407c8d6a1b993a388b21
5 N2c114afaabc846e3871a9fa4815e412c
6 N4e32f61506cf4db0b2c199f02318085a
7 N9039878d66d4452cac2d908c1f757ea3
8 Nae7e78d7bfac4b7fa344f2ebfa704bd1
9 Nb5431428b9834afe873c42344f1b34f5
10 Nbccb749c4c9e479a94c6711802513606
11 Nc4830b48775b46b585c4698be6ca9e2b
12 Nd6467fd4ae6a4847a60975b986da43aa
13 Ne40f9f93ff254a15806abd69e3f5fb3b
14 Ne6daaf7eb1fb4bddbfe81d4af8fad1b1
15 Ne8a6fadd05f2487688a91444482b2a92
16 Nf3c4c25d14e346d086b06c6ca2539075
17 anzsrc-for:11
18 anzsrc-for:1112
19 schema:author N965f8dcb706249b89298a44793459e42
20 schema:citation sg:pub.10.1007/82_2010_67
21 sg:pub.10.1007/s00210-014-1032-y
22 sg:pub.10.1007/s00401-016-1545-1
23 sg:pub.10.1007/s11060-016-2220-z
24 sg:pub.10.1038/nrclinonc.2013.10
25 sg:pub.10.1186/1741-7007-10-29
26 sg:pub.10.1186/1756-8722-7-1
27 sg:pub.10.1186/s13014-015-0475-8
28 https://app.dimensions.ai/details/publication/pub.1079157684
29 https://app.dimensions.ai/details/publication/pub.1083005077
30 https://doi.org/10.1016/j.cell.2013.09.034
31 https://doi.org/10.1016/j.gene.2004.04.032
32 https://doi.org/10.1016/j.mrfmmm.2011.03.007
33 https://doi.org/10.1016/j.radonc.2011.06.007
34 https://doi.org/10.1016/s1470-2045(09)70025-7
35 https://doi.org/10.1093/neuonc/nop026
36 https://doi.org/10.1093/neuonc/nou223
37 https://doi.org/10.1111/j.1432-1033.1981.tb06218.x
38 https://doi.org/10.1111/pcmr.12227
39 https://doi.org/10.1128/mcb.06053-11
40 https://doi.org/10.1158/0008-5472.can-10-2889
41 https://doi.org/10.1158/0008-5472.can-15-2402
42 https://doi.org/10.1158/1078-0432.ccr-12-1141
43 https://doi.org/10.1158/1535-7163.mct-09-1012
44 https://doi.org/10.1158/1535-7163.mct-11-0606
45 https://doi.org/10.1158/1535-7163.mct-14-0708
46 https://doi.org/10.1158/1541-7786.mcr-11-0592
47 https://doi.org/10.1200/jco.2011.35.5263
48 https://doi.org/10.1242/jcs.00712
49 https://doi.org/10.1369/0022155411400867
50 https://doi.org/10.2174/138161213804547286
51 https://doi.org/10.3892/br.2016.594
52 https://doi.org/10.4161/15384047.2014.961876
53 https://doi.org/10.4161/cbt.25939
54 https://doi.org/10.4161/cc.10.13.16305
55 schema:datePublished 2017-12
56 schema:datePublishedReg 2017-12-01
57 schema:description BACKGROUND: Glioblastoma multiforme (GBM) is the most common, invasive and deadly primary type of malignant brain tumor. The Phosphatidylinositol-3-Kinase/AKT (PI3K/AKT) pathway is highly active in GBM and has been associated with increased survival and resistance to therapy. The aim of this study is to investigate the effects of AKT inhibition in combination with the current standard of care which consists of irradiation and temozolomide (TMZ) on human malignant glioma cells growing adherent and as multicellular spheroids in vitro. METHODS: The effects of the allosteric inhibitor MK2206 combined with irradiation and TMZ were assessed on glioma cells growing adherent and as multicellular 3D spheroids. The interaction was studied on proliferation, clonogenic cell survival, cell invasion, -migration and on expression of key proteins in the PI3K-AKT pathway by western blot. RESULTS: A differential effect was found at low- (1 μM) and high dose (10 μM) MK2206. At 1 μM, the inhibitor reduced phosphorylation of Thr308 and Ser473 residues of AKT in both adherent cells and spheroids. Low dose MK2206 delayed spheroid growth and sensitized spheroids to both irradiation and TMZ in a synergistic way (Combination index <0.35). In contrast, neither low nor high dose MK2206 did enhance therapy sensitivity in adherent growing cells. Effective inhibition of invasion and migration was observed only at higher doses of MK2206 (>5 μM). CONCLUSIONS: The data show that a 3D spheroid model show different sensitivity to irradiation when combined with AKT inhibition. Thereby we show that MK2206 has potential synergistic efficacy to the current standard of care for glioma patients.
58 schema:genre research_article
59 schema:inLanguage en
60 schema:isAccessibleForFree true
61 schema:isPartOf Na72091a6cb4f4c02b2f675d6965cfe9d
62 Ndc8e7eb30b67441b8343a83ae21e0cae
63 sg:journal.1024632
64 schema:name The allosteric AKT inhibitor MK2206 shows a synergistic interaction with chemotherapy and radiotherapy in glioblastoma spheroid cultures
65 schema:pagination 204
66 schema:productId N0dee88e50b8c4b9b98276a098daf021a
67 N216504ca1a9a434b9193e3c788be73d7
68 N5c24404ad988426680bdb29d90f72a76
69 N5f9d5e1344ad4f288469fcbcca1fdda8
70 N7ab98691e9d14f2a98a142c429496d90
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084250541
72 https://doi.org/10.1186/s12885-017-3193-9
73 schema:sdDatePublished 2019-04-11T10:36
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher N9ced61a178664c89bd7ef392c00df99e
76 schema:url https://link.springer.com/10.1186%2Fs12885-017-3193-9
77 sgo:license sg:explorer/license/
78 sgo:sdDataset articles
79 rdf:type schema:ScholarlyArticle
80 N078840cc60fa44d18cdde46558b752b5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Humans
82 rdf:type schema:DefinedTerm
83 N0a52156e22ff478bb652c95474b53911 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Cell Proliferation
85 rdf:type schema:DefinedTerm
86 N0dee88e50b8c4b9b98276a098daf021a schema:name nlm_unique_id
87 schema:value 100967800
88 rdf:type schema:PropertyValue
89 N10c090810eb34f078e902de000a50602 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Proto-Oncogene Proteins c-akt
91 rdf:type schema:DefinedTerm
92 N123bb7312e3f407c8d6a1b993a388b21 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Glioblastoma
94 rdf:type schema:DefinedTerm
95 N16fb2aca29214b1293bdcb248cee7299 rdf:first sg:person.0676345051.76
96 rdf:rest rdf:nil
97 N1bf72d67914a4731be4f065f1bc45352 rdf:first sg:person.014562057203.48
98 rdf:rest N8c331ccffd14492698f520863dde7f42
99 N1f02cdc6eb0b4cbd8dc9f5db9c7b8428 rdf:first sg:person.0721552575.80
100 rdf:rest Na035ea39797744c581da88025d218688
101 N216504ca1a9a434b9193e3c788be73d7 schema:name readcube_id
102 schema:value becaedf7c320b6d1374970cf95f398c081e03d059484160acc593c2382fb9096
103 rdf:type schema:PropertyValue
104 N225021554cce4d66aadaa4bba0864c6f schema:name Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands
105 rdf:type schema:Organization
106 N2c114afaabc846e3871a9fa4815e412c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Phosphorylation
108 rdf:type schema:DefinedTerm
109 N3fb43f1c618143debae8e4db738ea87d schema:name Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands
110 rdf:type schema:Organization
111 N4e32f61506cf4db0b2c199f02318085a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Dacarbazine
113 rdf:type schema:DefinedTerm
114 N5c24404ad988426680bdb29d90f72a76 schema:name doi
115 schema:value 10.1186/s12885-017-3193-9
116 rdf:type schema:PropertyValue
117 N5f9d5e1344ad4f288469fcbcca1fdda8 schema:name pubmed_id
118 schema:value 28320338
119 rdf:type schema:PropertyValue
120 N6c0ca5d94d7c465481ee90cdab942641 schema:affiliation N225021554cce4d66aadaa4bba0864c6f
121 schema:familyName Brands
122 schema:givenName Eelke
123 rdf:type schema:Person
124 N7ab98691e9d14f2a98a142c429496d90 schema:name dimensions_id
125 schema:value pub.1084250541
126 rdf:type schema:PropertyValue
127 N8c331ccffd14492698f520863dde7f42 rdf:first sg:person.011141072757.33
128 rdf:rest Nb086f5baa2e34930bb9f2259c06a5f3f
129 N9039878d66d4452cac2d908c1f757ea3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Cell Line, Tumor
131 rdf:type schema:DefinedTerm
132 N965f8dcb706249b89298a44793459e42 rdf:first sg:person.01107655364.11
133 rdf:rest Nfe9c73e05685421abd653a041d6356ab
134 N9ced61a178664c89bd7ef392c00df99e schema:name Springer Nature - SN SciGraph project
135 rdf:type schema:Organization
136 Na035ea39797744c581da88025d218688 rdf:first sg:person.01255301342.17
137 rdf:rest N16fb2aca29214b1293bdcb248cee7299
138 Na72091a6cb4f4c02b2f675d6965cfe9d schema:issueNumber 1
139 rdf:type schema:PublicationIssue
140 Nae7e78d7bfac4b7fa344f2ebfa704bd1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Signal Transduction
142 rdf:type schema:DefinedTerm
143 Nb086f5baa2e34930bb9f2259c06a5f3f rdf:first sg:person.0641065010.31
144 rdf:rest Nc3f230a3e437455bb766d2d78a82b7e7
145 Nb5431428b9834afe873c42344f1b34f5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Blotting, Western
147 rdf:type schema:DefinedTerm
148 Nbccb749c4c9e479a94c6711802513606 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Brain Neoplasms
150 rdf:type schema:DefinedTerm
151 Nc1c23feac6244127bb78ad446b9564d5 schema:name Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands
152 rdf:type schema:Organization
153 Nc3f230a3e437455bb766d2d78a82b7e7 rdf:first sg:person.01112041340.57
154 rdf:rest N1f02cdc6eb0b4cbd8dc9f5db9c7b8428
155 Nc4830b48775b46b585c4698be6ca9e2b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Spheroids, Cellular
157 rdf:type schema:DefinedTerm
158 Ncefcd1866c4449b7b3269ed9a52cc651 schema:name Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands
159 rdf:type schema:Organization
160 Nd6467fd4ae6a4847a60975b986da43aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Antineoplastic Agents, Alkylating
162 rdf:type schema:DefinedTerm
163 Nd908e4d22de045daa241db438092d831 schema:name Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands
164 rdf:type schema:Organization
165 Nda806c0c655244b0a18399c909a32b88 schema:name Department of Radiation Oncology, VU University Medical Center/Cancer Center Amsterdam, P.O. Box 7057, 1007, Amsterdam, MB, The Netherlands
166 rdf:type schema:Organization
167 Ndc8e7eb30b67441b8343a83ae21e0cae schema:volumeNumber 17
168 rdf:type schema:PublicationVolume
169 Ne40f9f93ff254a15806abd69e3f5fb3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Phosphatidylinositol 3-Kinase
171 rdf:type schema:DefinedTerm
172 Ne6daaf7eb1fb4bddbfe81d4af8fad1b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Heterocyclic Compounds, 3-Ring
174 rdf:type schema:DefinedTerm
175 Ne8a6fadd05f2487688a91444482b2a92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Temozolomide
177 rdf:type schema:DefinedTerm
178 Nec6cc99e852d48f2b0e82fe8b8d7f44c rdf:first N6c0ca5d94d7c465481ee90cdab942641
179 rdf:rest N1bf72d67914a4731be4f065f1bc45352
180 Nf3c4c25d14e346d086b06c6ca2539075 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Drug Synergism
182 rdf:type schema:DefinedTerm
183 Nfe9c73e05685421abd653a041d6356ab rdf:first sg:person.01350727612.68
184 rdf:rest Nec6cc99e852d48f2b0e82fe8b8d7f44c
185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
186 schema:name Medical and Health Sciences
187 rdf:type schema:DefinedTerm
188 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
189 schema:name Oncology and Carcinogenesis
190 rdf:type schema:DefinedTerm
191 sg:journal.1024632 schema:issn 1471-2407
192 schema:name BMC Cancer
193 rdf:type schema:Periodical
194 sg:person.01107655364.11 schema:affiliation Nc1c23feac6244127bb78ad446b9564d5
195 schema:familyName Narayan
196 schema:givenName Ravi S.
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01107655364.11
198 rdf:type schema:Person
199 sg:person.01112041340.57 schema:affiliation Ncefcd1866c4449b7b3269ed9a52cc651
200 schema:familyName Slotman
201 schema:givenName Ben J.
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112041340.57
203 rdf:type schema:Person
204 sg:person.011141072757.33 schema:affiliation https://www.grid.ac/institutes/grid.5650.6
205 schema:familyName Stalpers
206 schema:givenName Lukas J.A.
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011141072757.33
208 rdf:type schema:Person
209 sg:person.01255301342.17 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
210 schema:familyName Peters
211 schema:givenName Godefridus J.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255301342.17
213 rdf:type schema:Person
214 sg:person.01350727612.68 schema:affiliation Nda806c0c655244b0a18399c909a32b88
215 schema:familyName Fedrigo
216 schema:givenName Carlos A.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350727612.68
218 rdf:type schema:Person
219 sg:person.014562057203.48 schema:affiliation Nd908e4d22de045daa241db438092d831
220 schema:familyName Dik
221 schema:givenName Rogier
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014562057203.48
223 rdf:type schema:Person
224 sg:person.0641065010.31 schema:affiliation https://www.grid.ac/institutes/grid.426577.5
225 schema:familyName Baumert
226 schema:givenName Brigitta G.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641065010.31
228 rdf:type schema:Person
229 sg:person.0676345051.76 schema:affiliation N3fb43f1c618143debae8e4db738ea87d
230 schema:familyName Sminia
231 schema:givenName Peter
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0676345051.76
233 rdf:type schema:Person
234 sg:person.0721552575.80 schema:affiliation https://www.grid.ac/institutes/grid.16872.3a
235 schema:familyName Westerman
236 schema:givenName Bart A.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0721552575.80
238 rdf:type schema:Person
239 sg:pub.10.1007/82_2010_67 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034849918
240 https://doi.org/10.1007/82_2010_67
241 rdf:type schema:CreativeWork
242 sg:pub.10.1007/s00210-014-1032-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1033781917
243 https://doi.org/10.1007/s00210-014-1032-y
244 rdf:type schema:CreativeWork
245 sg:pub.10.1007/s00401-016-1545-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021788062
246 https://doi.org/10.1007/s00401-016-1545-1
247 rdf:type schema:CreativeWork
248 sg:pub.10.1007/s11060-016-2220-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1008754431
249 https://doi.org/10.1007/s11060-016-2220-z
250 rdf:type schema:CreativeWork
251 sg:pub.10.1038/nrclinonc.2013.10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031948211
252 https://doi.org/10.1038/nrclinonc.2013.10
253 rdf:type schema:CreativeWork
254 sg:pub.10.1186/1741-7007-10-29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006008752
255 https://doi.org/10.1186/1741-7007-10-29
256 rdf:type schema:CreativeWork
257 sg:pub.10.1186/1756-8722-7-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033613173
258 https://doi.org/10.1186/1756-8722-7-1
259 rdf:type schema:CreativeWork
260 sg:pub.10.1186/s13014-015-0475-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049118084
261 https://doi.org/10.1186/s13014-015-0475-8
262 rdf:type schema:CreativeWork
263 https://app.dimensions.ai/details/publication/pub.1079157684 schema:CreativeWork
264 https://app.dimensions.ai/details/publication/pub.1083005077 schema:CreativeWork
265 https://doi.org/10.1016/j.cell.2013.09.034 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044472205
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1016/j.gene.2004.04.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043587272
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1016/j.mrfmmm.2011.03.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013050931
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1016/j.radonc.2011.06.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042768064
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1016/s1470-2045(09)70025-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002463620
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1093/neuonc/nop026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007120656
276 rdf:type schema:CreativeWork
277 https://doi.org/10.1093/neuonc/nou223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019576806
278 rdf:type schema:CreativeWork
279 https://doi.org/10.1111/j.1432-1033.1981.tb06218.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1052409919
280 rdf:type schema:CreativeWork
281 https://doi.org/10.1111/pcmr.12227 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022196975
282 rdf:type schema:CreativeWork
283 https://doi.org/10.1128/mcb.06053-11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049824220
284 rdf:type schema:CreativeWork
285 https://doi.org/10.1158/0008-5472.can-10-2889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047303951
286 rdf:type schema:CreativeWork
287 https://doi.org/10.1158/0008-5472.can-15-2402 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051494246
288 rdf:type schema:CreativeWork
289 https://doi.org/10.1158/1078-0432.ccr-12-1141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045845537
290 rdf:type schema:CreativeWork
291 https://doi.org/10.1158/1535-7163.mct-09-1012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016692533
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1158/1535-7163.mct-11-0606 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019719324
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1158/1535-7163.mct-14-0708 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007436827
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1158/1541-7786.mcr-11-0592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013402033
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1200/jco.2011.35.5263 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022896731
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1242/jcs.00712 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016424950
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1369/0022155411400867 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035146448
304 rdf:type schema:CreativeWork
305 https://doi.org/10.2174/138161213804547286 schema:sameAs https://app.dimensions.ai/details/publication/pub.1069168528
306 rdf:type schema:CreativeWork
307 https://doi.org/10.3892/br.2016.594 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071502597
308 rdf:type schema:CreativeWork
309 https://doi.org/10.4161/15384047.2014.961876 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072288009
310 rdf:type schema:CreativeWork
311 https://doi.org/10.4161/cbt.25939 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072292971
312 rdf:type schema:CreativeWork
313 https://doi.org/10.4161/cc.10.13.16305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072295972
314 rdf:type schema:CreativeWork
315 https://www.grid.ac/institutes/grid.16872.3a schema:alternateName VU University Medical Center
316 schema:name Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands
317 Department of Neurosurgery, Neuro Oncology Research Group, VU University Medical Center, Amsterdam, The Netherlands
318 rdf:type schema:Organization
319 https://www.grid.ac/institutes/grid.426577.5 schema:alternateName Maastro Clinic
320 schema:name Clinical Cooperation Unit Neurooncology, MediClin Robert Janker Klinik & University of Bonn Medical Center, Bonn, Germany
321 Department of Radiation Oncology, Maastro Clinic, Maastricht, The Netherlands
322 rdf:type schema:Organization
323 https://www.grid.ac/institutes/grid.5650.6 schema:alternateName Academic Medical Center
324 schema:name Department of Radiation Oncology, Academic Medical Center, Amsterdam, The Netherlands
325 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...